BIGEY; PASCAL

Patent Applications and Registrations

Patent applications and USPTO patent grants for BIGEY; PASCAL.The latest application filed is for "nucleic acid vector tablets".

Company Profile

1.6.10

BIGEY; PASCAL - PARIS FR
Bigey, Pascal - Clermont-Ferrand FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nucleic Acid Vector Tablets App 20200163879 - BUSIGNIES-GODDIN; VIRGINIE ; et al.	2020-05-28
Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acids Grant 9,572,776 - Escriou , et al. February 21, 2	2017-02-21
Vaccines against pregnancy-associated malaria Grant 9,540,425 - Ndam , et al. January 10, 2	2017-01-10
Vaccines Against Pregnancy-associated Malaria App 20130129767 - Tuikue Ndam; Nicaise ; et al.	2013-05-23
Vectors Including An Anionic Macromolecule And A Cationic Lipid For Delivering Small Nucleic Acids App 20120093915 - Escriou; Virginie ; et al.	2012-04-19
Methods and devices for delivering a therapeutic product to the ocular sphere of a subject Grant 8,039,445 - Behar-Cohen , et al. October 18, 2	2011-10-18
Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method App 20100129371 - Scherman; Daniel ; et al.	2010-05-27
Methods And Devices For Delivering A Therapeutic Product To The Ocular Sphere Of A Subject App 20080183123 - Behar-Cohen; Francine ; et al.	2008-07-31
Dna demethylase antisense and chemotherapy combination App 20060009403 - Bigey; Pascal ; et al.	2006-01-12
System for regulating in vivo the expression of a transgene by conditional inhibition App 20050289658 - Scherman, Daniel ; et al.	2005-12-29
System for regulating in vivo the expression of a transgene by conditional inhibition App 20020166132 - Scherman, Daniel ; et al.	2002-11-07
Specific inhibitors of DNA methyltransferase App 20010041337 - Szyf, Moshe ; et al.	2001-11-15
DNA methyltransferase genomic sequences and antisense oligonucleotides Grant 6,221,849 - Szyf , et al. April 24, 2	2001-04-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.